2018 Annual Meeting
Identifying the Rare: Evolving Diagnostics Standards in Characterizing Cancer
Developed through the collaboration between the United States and Canadian Academy of Pathology (USCAP) and Medscape. Supported by an educational grant from Bayer and Loxo Oncology.
Tuesday, March 20, 2018, 6:00 - 7:45 AM
VCC West Ballroom D
6:00 - 6:15 AM Breakfast and Registration
6:15 - 7:45 AM Educational Session
Free session for those with general meeting registration
Add this free session to your meeting registration
If you need assistance, email the USCAP membership team.
Theodore W. Laetsch, MD
Department of Pediatrics – Hematology/Oncology
The University of Texas Southwestern Medical Center
Jaclyn F. Hechtman, MD
Department of Pathology
Memorial Sloan Kettering Cancer Center
New York, New York
Frédérique Penault-Llorca, MD, PhD
Department of Pathology and Tumor Biology
Chief Executive Officer
Jean Perrin Cancer Center
The number of targetable genetic alterations in solid tumors has been rapidly growing, concomitant with an increase in the number of approved therapeutic agents specific for genetic changes. This has led to significant changes in the screening and characterization of cancers that are used to direct treatment selection. The growing understanding of mechanisms of progression and the development of agents targeting molecular means of resistance have led to an increased need for repeat biopsy and additional molecular characterization upon progression. This symposium will explore current standards for molecular testing and best practices for sampling and communicating results.
|6:15 - 6:20 AM||Welcome and Introductions|
|6:20 - 6:50 AM||Characterizing Newly Diagnosed Cancer|
|6:50 - 7:15 AM||Recharacterizing Cancer Upon Progression|
|7:15 - 7:30 AM||Communicating Cancer Characteristics|
|7:30 - 7:35 AM||Clinical Pearls and Concluding Remarks|
|7:35 - 7:45 AM||Questions and Answer Session|
Continuing Medical Education and Maintenance of Certification
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.